Product Images Theophylline

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Theophylline NDC 72578-174 by Viona Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image - 1e5a0f45 86aa 498a 9cc3 9f7acc210ed6 01

Image - 1e5a0f45 86aa 498a 9cc3 9f7acc210ed6 01

300 mg - 1e5a0f45 86aa 498a 9cc3 9f7acc210ed6 02

300 mg - 1e5a0f45 86aa 498a 9cc3 9f7acc210ed6 02

This is a description for Theophylline Extended-Release Tablets with a strength of 300 mg. The package contains 100 tablets in a child-resistant packaging. The usual dosage information can be found in the package insert. The tablets should be stored in a controlled room temperature between 15°C to 30°C. The product is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India, and distributed by Viona Pharmaceuticals Inc. in Cranford, NJ 07016.*

450 mg - 1e5a0f45 86aa 498a 9cc3 9f7acc210ed6 03

450 mg - 1e5a0f45 86aa 498a 9cc3 9f7acc210ed6 03

Each uncoated extended-release tablet contains Theophylline (Anhydrous) USP, 450 mg. The usual dosage of Theophylline can be found in the package insert for prescribing information. Storage instructions include keeping the tablets at 20°C to 25°C (66°F to 77°F) with permitted excursions between 15°C to 30°C (59°F to 86°F). Dispense in a well-closed container with child-resistant closure. Manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India. Distributed by Viona Pharmaceuticals Inc. Rev. 0224.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.